Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

A man with severe hair loss saw hair and nail improvement after 10 months on tofacitinib without side effects.

Baricitinib shows promise for treating various skin conditions beyond alopecia areata.

5% topical minoxidil improves hair density and quality in monilethrix patients.

Erlotinib can cause acne-like skin issues, needing early treatment and possible dosage adjustments.

Unorthodox dosing of tofacitinib and baricitinib is safe but less effective than standard dosing for treating alopecia areata in kids.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

Blocking mTORC1 reduces skin tumor growth in mice.

Standard dosing is more effective for severe alopecia areata in children, but unorthodox dosing can be safe and considered if needed.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

Janus kinase inhibitors may effectively treat resistant scalp conditions like folliculitis decalvans and dissecting cellulitis.

Erlotinib can cause hair loss as a side effect.

ISX-9 helps stem cells heal lung injury better by boosting growth factor secretion.

Using minoxidil and tofacitinib together can effectively treat severe hair loss.

Some new isatin compounds could be strong cancer-fighting drugs because they fit well in cancer-related proteins and have good drug-like properties.

Sacituzumab Tirumotecan shows promise in treating gynecologic cancers with manageable side effects.

Tofacitinib effectively regrows hair in alopecia areata but may need continuous use.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

Tofacitinib was more effective than methotrexate for treating alopecia areata.

A bull with a gene mutation was asymptomatic, synthetic retinoids cause hair loss, and new therapeutic targets were identified for skin diseases.

The registry showed that tofacitinib is promising for treating hair loss in children with alopecia areata, but more research is needed.

Cetuximab often causes skin problems, but they can be managed without stopping treatment.

Bendamustine, often combined with other drugs, is effective and less toxic for certain blood cancers, but less effective for young, fit patients with CLL.

JAK inhibitors are effective and generally safe for treating alopecia areata, but monitoring for side effects is important.

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

Tofacitinib is effective and safe for treating alopecia areata.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Certain Chinese herbs may help treat kidney fibrosis by targeting TGF-β.